tiprankstipranks
Trending News
More News >

Pasithea Therapeutics Raises $6.3 Million in Stock Offering

Story Highlights
Pasithea Therapeutics Raises $6.3 Million in Stock Offering

Confident Investing Starts Here:

Pasithea Therapeutics Corp ( (KTTA) ) just unveiled an announcement.

On May 6, 2025, Pasithea Therapeutics Corp. entered into securities purchase agreements to sell shares of common stock and warrants, raising approximately $6.3 million in gross proceeds. The company plans to use the net proceeds of $4.3 million for general corporate purposes, including research, clinical trials, and potential acquisitions. The offering closed on May 7, 2025, with H.C. Wainwright & Co. acting as the exclusive placement agent.

More about Pasithea Therapeutics Corp

Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focused on discovering, researching, and developing innovative treatments for central nervous system disorders, RASopathies, and MAPK pathway-driven tumors.

Average Trading Volume: 5,612,569

Technical Sentiment Signal: Sell

Current Market Cap: $4.5M

For a thorough assessment of KTTA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App